Ligand · LID
LID · 8-(2-chlorophenylamino)-2-(2,6-difluorophenylamino)-9-ethyl-9H-purine-1,7-diium
LID, 8-(2-chlorophenylamino)-2-(2,6-difluorophenylamino)-9-ethyl-9H-purine-1,7-diium (C19 H15 Cl F2 N6, 400.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…
- Component
- LID
- Formula
- C19 H15 Cl F2 N6
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LID in 2 structures; the first of them:
- 2GTM · Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579 · LID A353 · binds VAL30, VAL38, ALA51, VAL52, LYS53, GLU71, LEU75, ILE84 and 15 more
- 2GTM · Mutated mouse P38 MAP kinase domain in complex with inhibitor pg- 892579 · LID A353 · binds VAL30, VAL38, ALA51, VAL52, LYS53, GLU71, LEU75, ILE84 and 15 more
Residues it binds most
LEU 2, ALA 2, VAL 2, ASP 2, GLY 2, GLU 2, HIS 2, ILE 2, LYS 2, MET 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.